Real-time enrollment status for this sst2-positive neuroendocrine neoplasms clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:48 AM UTC
| NCT Number | NCT07129252 |
| Recruiting Status | Recruiting |
| Condition | SST2-positive Neuroendocrine Neoplasms |
| Phase | Clinical Trial |
| Target Enrollment | 150 participants |
| Active Locations | 22 sites in the US |
| Sponsor | Crinetics Pharmaceuticals Inc. |
| Last Updated on CT.gov | July 1, 2026 (1 week ago) |
As of July 13, 2026: Clinical trial NCT07129252 is currently recruiting participants. This clinical trial study for sst2-positive neuroendocrine neoplasms is actively seeking new participants at 22 locations across the United States. The study is sponsored by Crinetics Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07129252 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07129252 was last updated 1 week ago (July 1, 2026). HelloStudys verifies this status automatically.